Casdin Capital
The new funding round was led by GV with participation from Bain Capital Ventures, Casdin Capital and Define Ventures.
The company's platform helps patients navigate care following testing, while also offering virtual expert consultations to doctors.
Mail-order personal genetics service and research company 23andMe has completed a $115 million in a round led by Fidelity Management and Research Company with participation from Casdin Capital, WuXi Healthcare Ventures, and Xfund, as well as existing investors Illumina, New Enterprise Associates, MPM Capital, and Google Ventures.